A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia

Running trials

• Recruiting

  PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

  NCT07256158· Phase 3· Source

• Not yet recruiting

  Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

  NCT07476105· Source

• Recruiting

  Study on Plasmablastic Lymphoma Patients

  NCT06781359· Source

• Active, not recruiting

  Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

  NCT06070961· Source

• Recruiting

  Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

  NCT05816850· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Follicular lymphoma2 recruiting
• Childhood cancers1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Hodgkin lymphoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

  NCT05966233· Phase 2· Source

• Completed

  Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

  NCT05066555· Source

• Completed

  FIL Study on ABVD DD-DI as Upfront Therapy in HL.

  NCT03159897· Phase 3· Source